Humana Inc. (HUM) Business Profile

What it does

Humana is a Louisville, Kentucky-based health insurer and care-services company led by President and Chief Executive Officer James A. Rechtin. It operates two segments: Insurance and CenterWell.

Its Insurance segment sells health coverage and related services. The main business is Medicare Advantage, where eligible people can choose a Humana plan instead of traditional Medicare. These plans combine hospital and medical coverage with services such as care coordination, wellness programs, chronic-care management and, in most cases, prescription-drug coverage. Humana also sells Medicare prescription-drug plans, Medicare supplement policies, dental, vision, life and disability coverage, and Medicaid plans under state contracts. It administers health-care services for military beneficiaries under its TRICARE contract.

CenterWell provides services that can be used by Humana members and other customers. Its operations include mail-order, specialty and clinic pharmacies; senior-focused primary-care clinics; care-management services for physicians; home health; infusion services; and durable medical equipment coordination. The company describes its model as linking the health plan with care delivery, aiming to coordinate care, engage members and help providers move from payment per service toward arrangements where payment depends partly on outcomes and total costs.

Humana had approximately 15 million medical-plan members and approximately 4.7 million specialty-product members at December 31, 2025.

How it makes money

Humana primarily receives premiums from members and government programs for assuming the cost of covered health care. Medicare Advantage is the central revenue source: Humana contracts with CMS and generally receives a fixed payment per member per month. That payment is adjusted for members’ demographics and documented health status. Members may also pay premiums, deductibles, copayments or coinsurance depending on the plan.

The Insurance segment also earns premiums from Medicare prescription-drug plans, Medicare supplements, specialty benefits and state Medicaid contracts. Its military-services business is different: the federal government retains the underlying medical-cost risk, so Humana records revenue net of estimated health-care costs, similarly to an administrative-services fee. Its pharmacy benefit manager business is also within Insurance.

CenterWell earns service revenue from pharmacy solutions, primary care and home solutions. It sells a substantial amount of these services to Humana’s Insurance customers; those intersegment sales are eliminated when the company reports consolidated results. Primary-care operations serve patients through Humana Medicare Advantage plans, other Medicare Advantage plans and CMS-administered risk-sharing arrangements.

FY2025 totals: The company reported $1.2 billion of net income attributable to Humana in 2025. Management said on the Q2 2026 call that it expected a full-year reduction of approximately 150 basis points in the consolidated operating cost ratio.

Customers and how it sells

Humana serves Medicare beneficiaries, Medicaid participants, people eligible for both programs, employers offering retiree coverage, employers and groups buying specialty coverage, individuals buying specialty products, and military personnel and their dependents. Medicare plans are offered in all 50 states.

At December 31, 2025, Humana covered approximately 5.2 million individual Medicare Advantage members through CMS contracts. Florida was a material concentration: approximately 1.0 million individual Medicare Advantage members were enrolled there, and the related contracts generated approximately $17.8 billion of premiums revenue in 2025. Those contracts represented approximately 20% of individual Medicare Advantage premiums revenue and 14% of consolidated premiums and services revenue.

Government business is central to the customer base. Contracts with the federal government generated 83% of total premiums and services revenue in 2025. Humana also serves Medicaid members in Florida, Kentucky, Illinois, Indiana, Louisiana, Ohio, Oklahoma, South Carolina, Virginia and Wisconsin. Its T-5 TRICARE East Region contract covers 24 states and Washington, D.C., and approximately 4.6 million beneficiaries.

The company markets through television, radio, the internet, telemarketing, direct mail, wholesalers, employed sales representatives, independent brokers and agents. It has a marketing arrangement with Walmart Inc. for a co-branded Medicare prescription-drug plan.

Suppliers and costs

Health-care providers are Humana’s key operating partners and a major source of costs. Its networks include employed and contracted physicians, hospitals, outpatient facilities, pharmacies, laboratories, home-health agencies, mental-health providers, nursing homes and other ancillary providers. The company typically pays hospitals using daily rates, case rates or discounted charges, while physician reimbursement commonly follows fixed fee schedules tied to Medicare allowable amounts.

Humana also shares financial risk with some providers. At December 31, 2025, approximately 2,260,900 members were covered under shared-risk value-based arrangements that provide all member benefits. In a capitation arrangement, the company prepays a provider a fixed monthly amount per member for a defined set of benefits, though Humana remains responsible if a provider fails to deliver covered services.

Benefits expense is driven by medical utilization, provider prices and prescription-drug costs. Other costs include claims processing, member service, marketing, technology, administration and clinic operations. Management said on the Q2 2026 call that its 2026 cost-trend assumption was seven to 8% including medical and pharmacy costs, with drug costs in the double digits.

Competitive position

Humana competes in local health-benefits markets with managed-care companies, national insurers, HMOs and PPOs. The company states that many competitors have larger membership bases or greater financial resources in the markets where it operates. CVS Health is named in reporting on Medicare Advantage coding and regulatory scrutiny, and Molina Healthcare is identified as a peer in reporting on Humana’s share-price performance.

Competition can affect member retention, benefit design, provider-network breadth, plan pricing, sales channels and Medicare quality ratings. Humana’s stated operating focus includes using its member base and care-delivery operations to negotiate provider terms, coordinate care and place more members in value-based arrangements. At December 31, 2025, approximately 3,586,100 individual Medicare Advantage members, or 68%, were in value-based relationships.

Our reading: Humana’s Medicare scale and its provider-network relationships are a moderate moat because membership can support provider discounts, but competitors with larger memberships and financial resources can also negotiate and invest.

Our reading: CenterWell’s pharmacy, primary-care and home-health operations are a moderate moat because they connect services with Humana members and risk-based care arrangements, although the company says segment profitability is interdependent and CenterWell also serves other customers.

Our reading: Quality execution is an important but uncertain competitive factor because the company seeks higher STARS revenue, while CMS thresholds are not known before final results.

Growth opportunities

Humana’s growth plans center on Medicare Advantage, Medicaid and CenterWell services. Its Medicare strategy combines health-plan enrollment with care management, provider relationships and value-based payment arrangements. The company aims to grow CenterWell’s pharmacy, primary-care and home-based services both within Humana and with external customers.

Primary care is a key part of this plan. At December 31, 2025, Humana operated 350 primary-care clinics, employed approximately 1,300 primary-care providers and served approximately 491,100 patients. CenterWell Home Health operated in 37 states and had approximately 68% geographic overlap with Humana’s individual Medicare Advantage membership.

Management said on the Q2 2026 call that Humana had been awarded a statewide Illinois Medicaid managed-care contract scheduled to begin in January 2027. Management also said it had acquired MaxHealth, while an announced divestiture of its minority interest in Gentiva was expected to largely fund that acquisition. It said that 2027 Medicare Advantage plan exits were expected to affect approximately 600,000 members, while it would seek to recapture a significant portion of those members.

The company expects its approach to 2027 to support progress toward a sustainable pre-tax margin of at least 3% in 2028. It also expects 2027 margin expansion to come from clinical work, operating efficiency, plan-benefit adjustments and targeted plan exits.

Structural risks

• Medical-cost and pricing risk. If premiums are not sufficient to cover members’ health-care costs, or if benefit-expense estimates are inadequate, profitability may be materially adversely affected. Medical utilization, inflation, costly treatments and prescription-drug spending can raise costs.

• Government-program concentration. Federal-government contracts generated 83% of premiums and services revenue in 2025. Medicare Advantage payments, risk adjustment, Part D rules, member eligibility and plan requirements can change through legislation, regulation or CMS policy.

• Provider and value-based-care risk. Humana relies on employed and contracted providers, including providers that assume financial risk. It remains financially responsible for members’ health-care services if providers fail to provide them.

• Regulatory, audit and compliance risk. The company is subject to federal and state rules governing health insurance, privacy, fraud and abuse, marketing, network management, claims and capital. Medicare Advantage diagnosis coding and RADV audits can affect risk-adjusted premium payments.

• Competitive and ratings risk. Competitors may have larger membership bases or greater financial resources. A ratings downgrade could make Humana less competitive, reduce customer confidence and increase future borrowing costs.

• Execution risk. The company is changing its operating model, centralizing functions, outsourcing selected work and pursuing cost and productivity initiatives. It expects to incur additional charges over the course of its transformation program.

Bottom line

Our reading

Our reading: Humana is principally a government-program health insurer, with individual Medicare Advantage as its largest business, and it is building a connected care-delivery model through CenterWell’s pharmacy, primary-care and home-health operations. Its economics depend on setting premiums and benefits appropriately against medical and drug costs, while managing provider arrangements and government reimbursement. The business has meaningful Florida and federal-program exposure, and its margin plan depends on operational efficiency, plan changes, clinical management and Medicare quality execution.